Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries
NCT ID: NCT04198571
Last Updated: 2024-03-26
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
317 participants
OBSERVATIONAL
2020-05-17
2021-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia
NCT01666743
Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults
NCT01940731
Effects of Neutrophil Extracellular Traps and Damage-associated Molecular Pattern Molecules on Long Term Use of Macrolides in Adults With Chronic Respiratory Disease
NCT05575726
Outcomes of Patients Not Responding to Antibiotics in the Community
NCT00245427
Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia
NCT00509106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Zinforo Treated
Only those Adults treated with this treatment for CAP or cSSTi
Zinforo (ceftaroline fosamil)
IV Solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Zinforo (ceftaroline fosamil)
IV Solution
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Received four (4) or more consecutive IV doses of Zinforo® in usual care on or before 31-May-2019; and
3. Admitting diagnosis to the hospital was either CAP or cSSTI.
Exclusion Criteria
2. Patients whose hospital medical records are missing documentation of the diagnostic criteria for either cSSTI or CAP;
3. Patients whose hospital medical records are missing details of dosing with Zinforo®;
4. Patients whose hospital medical records are missing information on the success/failure of Zinforo® treatment and the reason why treatment was discontinued; and
5. Patients whose hospital medical records are missing discharge date and status information.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Real Hospital Português de Beneficência
Recife, Pernambuco, Brazil
Hospital Esperança
Recife, , Brazil
Clínica Las Américas
Medellín, Antioquia, Colombia
E.S.E. Hospital Universitario San Jorge de Pereira
Pereira, Risaralda Department, Colombia
Fundación Valle del Lili
Cali, Valle del Cauca Department, Colombia
Centro médico Imbanaco
Cali, , Colombia
CHU Francois Mitterrand
Dijon, , France
CHU de Grenoble Alpes
Grenoble, , France
Croix-Rousse hospital, Hospices Civils de Lyon
Lyon, , France
CHU Nantes
Nantes, , France
Attikon University General Hospital
Athens, , Greece
University Hospital of Heraklion
Heraklion, , Greece
General University Hospital of Larissa
Larissa, , Greece
Patras University Medical School
Pátrai, , Greece
AHEPA General University Hospital of Thessaloniki
Thessaloniki, , Greece
Asst Spedali Civili Brescia and Universita Degli Studi di Brescia
Brescia, Other, Italy
AORN Ospedali dei Colli - Ospedale Monaldi
Napoli, Other, Italy
Azienda Ospedaliera Dei Colli
Napoli, , Italy
Aou Citta Della Salute E Della Scienza Scdu Malattie Infettive 2
Turin, , Italy
Azienda Sanitaria Universitaria Friuli Centrale (ASU FC), Presidio Ospedaliero Universitario Santa
Udine, , Italy
Republican Clinical Hospital named after G.G. Kuvatova
Ufa, Bashkortostan Republic, Russia
BUZ UR First Republican Clinical Hospital under the Ministry of Healthcare of Udmurt Republic UR
Izhevsk, Udmurtiya Republic, Russia
Hospital Clínic
Barcelona, , Spain
Hospital Universitario Valle de Hebrón
Barcelona, , Spain
Hospital Ramon y Cajal
Madrid, , Spain
Hospital Universitario 12 de Octubre
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ferry T, Gogos C, Soriano A, Blasi F, Ansari W, Kantecki M, Schweikert B, Luna G, Bassetti M. Real-World Use and Treatment Outcomes of Ceftaroline Fosamil in Patients with Complicated Skin and Soft Tissue Infection: A Multinational Retrospective Study. Infect Drug Resist. 2024 Jul 4;17:2773-2783. doi: 10.2147/IDR.S455515. eCollection 2024.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C2661041
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.